
Published On: Nov 2022
Published On: Nov 2022
At 7.0% CAGR, the North America Capnography Equipment Market is projected to be worth US$ 302.81 million by 2028, says Business Market Insights
According to Business Market Insights’ research, the North America capnography equipment market was valued at US$ 201.81 million in 2022 and is expected to reach US$ 302.81 million by 2028, registering an annual growth rate of 7.0% from 2022 to 2028. Clinical benefits of capnography equipment over pulse oximetry and prevalence of respiratory disorders are the critical factors attributed to the market expansion.
Pulse oximetry is a technique used to measure the oxygen level/saturation of the blood. The oxygen level is detected with the use of infrared and red light to determine the extent of oxygenation of hemoglobin. On the other hand, in capnography, CO2 absorbs infrared radiation, and thus, the procedure involves the passage of infrared radiation over a gas sample collected from exhalation. In many cases, oxygen levels in the blood can remain normal for several minutes after a patient stops breathing. Therefore, pulse oximetry can provide false positive results of the presence of oxygen in the blood. As capnography detects the CO2 present in the body, the detection is more accurate than pulse oximetry. The equipment can read every phase of the respiratory cycle, thereby providing more in-depth readings than those offered by pulse oximetry monitors. The ability of capnography machines to provide robust data sets makes it easier for healthcare providers to diagnose the root causes of respiratory problems. The capnograph wavelength displays the entire breathing cycle, making it easier to track exact symptoms. Capnography is used to understand how a patient is responding to treatment as they can display the ongoing data in real time. They can also be used to determine when a patient should be ventilated, in case of a patient progressing to respiratory failure. Pulse oximetry cannot detect respiratory conditions as they do not provide any data in real time. This, the advantages of capnography equipment over pulse oximetry are fueling the growth of the market.
On the contrary, stringent regulations for approval of capnography equipment hurdles the growth of North America capnography equipment market.
Key players dominating the North America capnography equipment market are BD, Dragerwerk AG & Co. KGaA, General Electric Company, Hill Rom Holding Inc. (Baxter), ICU Medical Inc., Koninklijke Philips N.V., Masimo, Medtronic, Nihon Kohden Corporation, and SCHILLER Americas Inc. among others.
Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com